Search Results for “Customizable SAP E_S4HCON2023 Practice Exam Software 🐂 Easily obtain ➠ E_S4HCON2023 🠰 for free download through ⇛ www.pdfvce.com ⇚ 🛐E_S4HCON2023 Exam Practice” – Page 19

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase

114

Maurer, M.+ Altrichter, S., Bieber, T., Biedermann, T., Bräutigam, M., Seyfried, S, Brehler, R., Grabbe, J., Hunzelmann, N., Jakob, T., Jung, A., Kleine-Tebbe, J., Mempel, M., Meurer, M., Reich, K., Ruëff, F., Sengupta, K., Sieder, C., Simon, J. C., Wedi, B., Zuberbier, T., Mahler, V., and Staubach, P.: Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase. J. Allergy Clin. Immunol. 2011: 128; 202-209. IF: 11.00

o.114

Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals

212

Hernández Fernández de Rojas, D.+, Ibáňez, E., Longhurst, H., Maurer, M. Fabien, V., Aberer, W., Bouillet, L., Zanichelli, A., and Caballero, T.: Treatment of HAE attacks in the icatibant outcome survey: an analysis of icatibant self-administration versus administration by health care professionals. Int. Arch. Allergy Immunol. 2015: 167; 21-28. IF: 2.67

377	Hawro, T., Hawro, M., Zalewska-Janowska, A., Weller, K., Metz, M., and Maurer M.+: Pruritus and sleep disturbances in patients with psoriasis. Arch. Dermat. Res. 2020: 312; 103-111. IF: 3.02

o.377

33	Peters, E. M., Maurer, M. Botchkarev, V. A., deMasey Jensen, K., Welker, P., Scott, G. A., and Paus, R.+: Kit is expressed by epithelial cells in vivo. J. Invest. Dermatol. 2003: 121; 976-984. IF: 4.19

260	Altrichter, S., Koch, K., Church, M. K., and Maurer, M.+: Atopic predisposition in cholinergic urticaria patients and its implications. J. Eur. Acad. Dermatol. Venereol. 2016: 30; 2060-2065. IF: 3.52

259	Hawro, T., Lehmann, S., Altrichter, S., Fluhr, J. W., Zuberbier, T., Church, M. K., Maurer, M.+ and Metz, M.: Skin provocation tests may help to diagnose atopic dermatitis. Allergy 2016: 71; 1745-1752. IF: 7.36

How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study

433.

Cherrez-Ojeda, I.⁺, Vanegas, E., Cherrez, A., Felix, M., Weller, K., Magerl, M., Maurer, R. R., Mata, V. L., Kasperska-Zajac, A., Sikora, A., Fomina, D., Kovalkova, E., Godse, K., Rao, N. D., Khoshkhui, M., Rastgoo, S., Criado, R. F. J., Abuzakouk, M., Grandon, D., Van Doorn, M. B. A., Rodrigues Valle, S. O., Magalhaes, E., De Souza Lima, E. M., Thomsen, S. F., Ramón, G. D., Matos Benavides, E. E., Bauer, A., Giménez-Arnau, A. M., Kocatürk, E., Guillet, C., Larco, J. I., Zhao, Z. T., Makris, M., Ritchie, C., Xepapadaki, P., Ensina, L. F., Cherrez, S., and Maurer, M.: How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study. World Allergy Organ. J. 2021: 14; e100542. IF: 5.52

o.433

374	Ertaş, R., Hawro, T., Altrichter, S., Özyurt, K., Erol, K., Ketenci Ertaş, S., and Maurer, M.+: Antinuclear antibodies are common and linked to poor response to omalizumab treatment in patients with CSU. Allergy 2020: 75; 468-470. IF: 13.15

o.374

Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany

475.

Weller, K.⁺, Maurer, M., Bauer, A., Wedi, B., Wagner, N., Schliemann, S., Kramps, T., Baeumer, D., Multmeier, J., Hillmann, E., and Staubach, P.: Epidemiology, comorbidities, and healthcare utilization of patients with chronic urticaria in Germany. J. Eur. Acad. Dermatol. Venereol. 2022: 36; 91-99. IF: 9.20

o.475

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series

482.

Maurer, M.⁺, Magerl, M., Aygören-Pürsün, E., Bork, K., Farkas, H., Longhurst, H., Kiani-Alikhan, S., Boullet, L., Boccon-Gibod, I., Cancian, M., Zanichelli, A., and Launay, D.: Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series. Allergy Asthma Clin. Immunol. 2022: 18; 4. IF: 2.70

o.482

Results